BARBIROLI, BRUNO
 Distribuzione geografica
Continente #
NA - Nord America 7.041
AS - Asia 5.738
EU - Europa 5.364
AF - Africa 355
SA - Sud America 307
Continente sconosciuto - Info sul continente non disponibili 276
OC - Oceania 13
Totale 19.094
Nazione #
US - Stati Uniti d'America 6.881
GB - Regno Unito 1.627
CN - Cina 1.608
VN - Vietnam 1.586
SG - Singapore 1.414
DE - Germania 840
IT - Italia 669
UA - Ucraina 478
SE - Svezia 473
HK - Hong Kong 393
FR - Francia 344
IN - India 284
RU - Federazione Russa 280
BR - Brasile 207
IE - Irlanda 182
JP - Giappone 107
CA - Canada 104
EE - Estonia 101
ZA - Sudafrica 99
CI - Costa d'Avorio 86
FI - Finlandia 74
NL - Olanda 74
KR - Corea 71
SC - Seychelles 69
AT - Austria 62
TG - Togo 53
AR - Argentina 39
BD - Bangladesh 36
PH - Filippine 32
NG - Nigeria 25
TH - Thailandia 25
JO - Giordania 24
BE - Belgio 23
BG - Bulgaria 23
CH - Svizzera 23
IR - Iran 22
ES - Italia 21
ID - Indonesia 20
UZ - Uzbekistan 16
GR - Grecia 15
MX - Messico 15
TR - Turchia 15
SA - Arabia Saudita 14
CL - Cile 13
HR - Croazia 13
EC - Ecuador 12
PK - Pakistan 12
TW - Taiwan 12
CO - Colombia 11
PL - Polonia 11
VE - Venezuela 11
LB - Libano 9
AU - Australia 8
CR - Costa Rica 8
JM - Giamaica 8
IQ - Iraq 7
PT - Portogallo 7
CZ - Repubblica Ceca 6
PE - Perù 6
PY - Paraguay 6
KE - Kenya 5
MY - Malesia 5
NZ - Nuova Zelanda 5
PR - Porto Rico 5
RO - Romania 5
HN - Honduras 4
KZ - Kazakistan 4
SY - Repubblica araba siriana 4
AO - Angola 3
DO - Repubblica Dominicana 3
MA - Marocco 3
NP - Nepal 3
PS - Palestinian Territory 3
SV - El Salvador 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
GT - Guatemala 2
LK - Sri Lanka 2
NI - Nicaragua 2
OM - Oman 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
ET - Etiopia 1
Totale 18.812
Città #
Southend 1.409
Singapore 940
Ashburn 541
Chandler 525
Ann Arbor 434
San Jose 425
Dong Ket 408
Hong Kong 371
Jacksonville 355
Fairfield 327
Council Bluffs 283
Princeton 270
Hefei 241
Ho Chi Minh City 235
Hanoi 229
Houston 226
Wilmington 224
Santa Clara 214
Beijing 194
Boardman 193
Dublin 180
Woodbridge 164
Frankfurt am Main 156
Seattle 128
Cambridge 121
Westminster 114
Padova 113
Los Angeles 111
Lauterbourg 108
Nanjing 98
Tokyo 97
New York 90
Abidjan 86
Berlin 86
Jinan 83
Medford 79
Milan 71
Saint Petersburg 71
Buffalo 65
Helsinki 65
Mülheim 57
Shenyang 56
Dallas 55
Seoul 54
Lomé 53
Bologna 46
Vienna 46
Da Nang 45
Mahé 45
Tianjin 45
Changsha 42
Guangzhou 42
Haiphong 34
Toronto 34
Hebei 33
San Diego 33
São Paulo 33
Turin 33
Nanchang 32
Redondo Beach 32
Phoenix 30
Verona 30
Chicago 29
Shanghai 28
Jiaxing 26
Amman 24
Rome 24
Zhengzhou 24
Abeokuta 23
Munich 23
Redwood City 23
Bengaluru 22
Brussels 22
Elora 21
Hangzhou 20
Norwalk 20
Sofia 20
Olalla 19
San Francisco 19
Bern 18
The Dalles 18
Atlanta 17
Bremen 17
Florence 16
Brooklyn 15
Dearborn 15
Des Moines 15
London 15
Bühl 14
Haikou 14
Hải Dương 13
Montreal 13
Shijiazhuang 13
Fuzhou 12
Ningbo 12
Costa Mesa 11
Shenzhen 11
Taizhou 11
Tongling 11
Falls Church 10
Totale 11.718
Nome #
Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy 354
Proton MR spectroscopy (1H-MRS), diffusion weighted imaging (DWI) and ultrasonography (US) in neonatal hypoglicaemia: a case report. 349
Proton MR spectroscopy (1H-MRS) and amplitude integrated EEG (aEEG) in predicting outcome in term newborns affected by hypoxic-ischemic encephalopathy (HIE). 340
Configurazioni di bobina di superficie a radiofrequenza per apparecchiatura di risonanza magnetica con migliorata sensibilita e selettività spaziale, ed apparecchiatura di risonanza magnetica comprendente una tale bobina 259
Abnormal ADC in the brain of prion disease patients: variation between brain structures. 259
Brain diffusion-weighted imaging in Friedreich's ataxia. 259
Defective Mitochondrial Adenosine Triphosphate Production in Skeletal Muscle From Patients With Dominant Optic Atrophy Due to OPA1 Mutations 257
Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. 255
Radio frequency surface coil designs for magnetic resonance apparatus with improved spatial sensitivity and selectivity, and a magnetic resonance apparatus including said coil 253
Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease 242
Clinical and neuroimaging evidence of interictal cerebellar dysfunction in FHM2. 237
A Study of the B1 Sensitivity Dependence of Transverse Field RF Surface Coils From the Spatial Orientation 232
The ND1 gene of complex I is a mutational hot spot for Leber's hereditary optic neuropathy. 229
Brain & Skeletal Muscle MRS Study in Patients with Myotonic Dystrophy Type 1 214
A novel Transverse Field RF Surface Coil for Clinical 1.5 T MRI and MRS Applications. 212
A case of fragile X premutation tremor/ataxia syndrome (FXTAS) with evidence of mitochondrial dysfunction 203
ADC and Proton Spectroscopy Reflect Cellular Pathology in Patients with Creutzfeldt-Jakob Disease 200
A novel Transverse Field RF Surface Coil for Clinical 1.5 T MRI and MRS Applications. 199
11C-Choline PET/TC for tumor localization of primary prostate cancer: comparison with 3-D proton MR spectroscopic imaging using radical prostatectomy specimen as standard of reference 199
PET-TC con 11C-colina e Spettroscopia di Risonanza Magnetica nella diagnosi e localizzazione del tumore prostatico: confronto con l'analisi seriata dello specimen chirurgico. 198
Brain Diffusion Weighted Imaging (DWI) Study of Friedreich's Ataxia Patients 197
31P- and 1H-MR spectroscopy studies in Familial Hemiplegic Migraine type 2 (FHM2). 193
Reduced in Vivo thalamic N-Acetyl-Aspartate is a Diagnostic Marker of Prion Disease 190
Quantitative mathematical expressions for accurate in vivo assessment of cytosolic [ADP] and deltaG of ATP hydrolysis in the human brain and skeletal muscle. 186
Pitfalls and advantages of different strategies for the absolute quantification of N-acetyl aspartate, creatine and choline in white and grey matter by 1H-MRS. 186
TOMOGRAFIA AD EMISSIONE DI POSITRONI CON 11-C-COLINA INTEGRATO A UN SISTEMA TC (11-C-CHOLINE-PET/TC) E RISONANZA MAGNETICA DI SPETTROSCOPIA DEL PROTONE (1-H-MRSI) NELLA DIAGNOSI DI NEOPLASIA PROSTATICA: STUDIO COMPARATIVO 186
Prostate biopsy directed on the basis of 3-D proton MR Spectroscopic Imaging findings in patients with prior negative biopsy 184
Improved 1.5 T Magnetic Resonance Spectroscopy in the Human Calf with a Spatially Selective Radio Frequency Surface Coil 184
Distribution of Diffusivity Changes in Subcortical Deep Gray Matter in Prion Diseases 184
La risonanza magnetica di diffusione differenzia la degenerazione corticobasale dalla paralisi sopranucleare progressiva e dalla malattia di Parkinson. 184
MR spectroscopy study of hypothalamic metabolism in narcolepsy and cluster headache. 183
Proton MR Spectroscopy (1H-MRS) and ampltude integrated EEG on predicting outcome in newborns affected by Hypoxic-Ischemic Encephalopathy (HIE) 182
An in vivo proton magnetic resonance spectroscopy study of thalamus in prion disease 182
The monoexponential pattern of phosphocreatine recovery after muscle exercise is a particular case of a more complex behaviour. 182
An in vivo proton magnetic resonance spectroscopy study of brain metabolism in early-onset Parkinson’s disease 181
Cerebellar proton mr spectroscopy study in friedreich’s ataxia patients 180
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson’s disease and progressive supranuclear palsy. 180
The 13042G>A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype. 179
Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease 178
Distribution of neurochemical abnormalities in patients with narcolepsy with cataplexy: an in vivo brain proton MR spectroscopy study. 176
Dominant Optic Atrophy (DOA) and Sensorineural Hearing Loss: Clinical, Biochemical, Spectroscopic and Molecular Genetic Study of a Large Italian Pedigree Linked to a New Locus on Chromosome 16 175
ADC Measurements in the Middle Cerebellar Peduncle Allows the Differentiation of MSA from PD and PSP 175
Effect of glutamine/glutamate increase on the N-acetylaspartate quantification in patients with hepatic encephalopathy assessed by 1H-MRS. 174
Proton Magnetic Resonance Spectroscopy Study of Brain Metabolism in Obstructive Sleep Apnoea Syndrome before and after Continuous Positive Airway Pressure Treatment 173
Sextant localization of prostate cancer:comparison between Magnetic Resonance Spectroscopic Imaging and 11C-Choline PET-CT. 173
Sextant localization of prostate cancer with 11-C-choline PET/CT: comparison with three-dimensional proton MR spectroscopic imaging using step section histopathology as standard of references 172
Deficit of in vivo mitochondrial ATP production in patients with OPA1-related autosomal dominant optic atrophy. A 31P-MRS study of the skeletal muscle. 170
Use of in vivo proton magnetic resonance spectroscopy in the differential diagnosis of prion diseases 170
Diffusion-weighted imaging study of patients with essential tremor. 170
Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease 170
Versatile coil design and positioning of transverse-field RF surface coils for clinical 1.5-T MRI applications. 168
Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. 168
Diffusion weighted imaging differentiates corticobasal degeneration from progressive supranuclear palsy and Parkinson’s disease. 168
The role of pH on the thermodynamics and kinetics of muscle biochemistry: an in vivo study by (31)P-MRS in patients with myo-phosphorylase deficiency. 168
Brain Diffusion Weighted Imaging Study of Friedreich Ataxia Patients 166
PET/TC CON 11-C-COLINA E SPETTROSCOPIA DO RISONANZA MAGNETICA NELLA DIAGNOSI E LOCALIZZAZIONE DEL TUMORE PROSTATICO: CONFRONTO CON LA ANALISI SERIATA DELLO SPICIMEN CHIRURGICO 165
Diffusion Weighted Imaging Study of Patients with Essential Tremor 164
Prion disease: an in vivo proton magnetic resonance spectroscopy study of thalamus. 163
Diffusion weighted imaging study of patients with essential tremor. 163
In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients. 161
Sextant localization of prostate cancer with 11-C-choline PET/CT: comparison with three-dimensional proton MR spectroscopic imaging using step section histopathology as standard of references 158
Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. 156
SEXTANT LOCALIZATION OF PROSTATE CANCER WITH 11C-CHOLINE PET/CT: COMPARISON WITH THREE-DIMENSIONAL PROTON MR SPECTROSCOPIC IMAGING USING STEP SECTION HISTOPATHOLOGY AS STANDARD OF REFERENCES 155
Cytosolic pH buffering during exercise and recovery in skeletal muscle of patients with McArdle’s disease 155
Diffusion weighted imaging study of patients with essential tremor. 154
The complex relationship between magnesium and serum parathyroid hormone: a study in patients with chronic intestinal failure 153
Carotid artery stenting: the high rate of silent cerebral embolic lesions on DWI is associated with aortic arch morphology 152
Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. 147
Autosomal dominant optic atrophy (ADO): different OPA1 mutations result in a deficit of in vivo mitochondrial ATP production 147
Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from PD 146
Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. 146
OPA1 Mutations Result in a Deficit of In Vivo Mitochondrial ATP Production in Patients with Autosomal Dominant Optic Atrophy 145
Secondary Involvement of Optic Radiation in Leber’s Hereditary Optic Neuropathy 145
Free Mg2+concentration in the calf muscle of glycogen phosphorylase and phosphofructokinase deficiency patients assessed in different metabolic conditions by 31P MRS. 144
Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor 144
Free Mg2+ concentration in the calf muscle of patients with glycogen phosphorylase and phosphofructokinase deficiency. A 31P MRS study in different metabolic conditions. 143
Diffusion-weighted imaging differentiates corticobasal degeneration from progressive supranuclear palsy and Parkinson’s disease. 143
Friedreich’s ataxia: an in vivo proton MR spectroscopy study of the cerebellum. 142
Diffusion Weighted Imaging (DWI) study of patients with essential tremor. 141
Assessment of glutamate and glutamine contribution to in vivo N-acetylaspartate quantification in human brain by 1H-Magnetic Resonance Spectroscopy 138
Combined DWI and 1H- MRS of the Brain of Cirrothic Patients 137
Proton MR Spectroscopy study of the cerebellum in Friedreich’s ataxia patients 136
Energy metabolism in migraine 136
Improved Proton MRS at 1.5 T with a Transverse Field RF Surface Coil. 135
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiates MSA from PD and PSP. 133
Deficit of in vivo mitochondrial ATP production in patients with OPA1-related autosomal dominant optic atrophy 132
Diffusion- weighted imaging discriminates MSA-P from PD 129
Distribution Of Diffusivity Changes In Subcortical Deep Gray Matter In Prion Diseases 129
Proton MR spectroscopy (1H-MRS), diffusion weighted imaging (DWI) and ultrasonography (US) in neonatal hypoglycemia: a case report 129
Pitfalls and advantages of different T2 correction strategies for the absolute quantification of Choline, N-Acetil Aspartate in human grey matter by 1H-MRS 127
PROSTATE BIOPSY DIRECTED ON THE BASIS OF 3-DIMENSIONAL PROTON MR SPECTROSCOPIC IMAGING FINDINGS IN PATIENTS WITH PRIOR NEGATIVE BIOPSY 127
In vivo magnetic resonance diagnostic surrogate markers in prion diseases (Contract n. QLK4-CT-2002-01763) 123
Narcolepsy-cataplexy associated with precocious puberty: a new form of hypothalamic dysfunction. 122
Cytosolic pH Buffering in Muscle of Patients with McArdle's Disease 121
Protected Carotid Artery Stenting: High Frequency of Silent Cerebral Embolic Lesions Detected by DWI 121
Prion disease: diffusion-weighted mri shows abnormalities in white and deep grey matter 120
Diffusion-weighted MRI shows abnormalities in white and deep grey matter of prion patients. 116
In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients 114
Early-onset Parkinson's disease: an in vivo proton MR spectroscopy study of brain metabolism. 113
MRI/3D-MRSI of Prostate to Direct TRUS-Guided Biopsy in Patients with Prior Negative Biopsy 111
Totale 17.468
Categoria #
all - tutte 51.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.782 0 0 0 124 170 109 59 126 62 281 454 397
2022/20232.456 278 354 184 348 191 176 56 126 387 49 210 97
2023/2024555 35 88 27 42 53 107 52 30 17 33 10 61
2024/20251.933 73 377 157 129 371 118 88 37 14 115 29 425
2025/20265.041 320 504 478 360 667 350 422 126 1.020 429 157 208
2026/20271.117 88 168 549 312 0 0 0 0 0 0 0 0
Totale 19.094